Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Farthing

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Lancet (London, England)|September 1, 1984
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in LondonB G Gazzard, D C Shanson, C Farthing, et al.
JAMA|September 29, 1999
HIV-1 drug resistance in newly infected individualsD Boden, A Hurley, L Zhang, et al.
AIDS (London, England)|August 1, 1991
The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative GroupD A Cooper, C Pedersen, F Aiuti, et al.
AIDS (London, England)|April 24, 2001
Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDSJ M Jacobson, R Hafner, J Remington, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials GroupH A Kessler, S Hurwitz, C Farthing, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potencyFranco Lori, R B Pollard, L Whitman, et al.
AIDS (London, England)|April 15, 1999
Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Lancet (London, England)|September 1, 1984
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in LondonB G Gazzard, D C Shanson, C Farthing, et al.
JAMA|September 29, 1999
HIV-1 drug resistance in newly infected individualsD Boden, A Hurley, L Zhang, et al.
AIDS (London, England)|August 1, 1991
The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative GroupD A Cooper, C Pedersen, F Aiuti, et al.
AIDS (London, England)|April 24, 2001
Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDSJ M Jacobson, R Hafner, J Remington, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials GroupH A Kessler, S Hurwitz, C Farthing, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potencyFranco Lori, R B Pollard, L Whitman, et al.
AIDS (London, England)|April 15, 1999
Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.
Pageof 3